STOCK TITAN

Tao Capital discloses 5.2% stake in Apnimed

Tao Capital Management, through affiliated investment entities, reports beneficial ownership of Apnimed, Inc. common stock on a passive basis.

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Tao Capital Management, through affiliated investment entities, reports beneficial ownership of Apnimed, Inc. common stock on a passive basis. The group holds 2,178,138 shares of common stock, representing 5.2% of the class, as of the reporting date.

The filing shows no sole voting or dispositive power; all 2,178,138 shares are subject to shared voting and shared dispositive power. The position is held via Tao Invest VI LLC, Tao Invest VII LLC, and Tao Invest VIII LLC, all organized in Delaware. Tao Capital Management LP is the managing member, and related entities and individuals disclaim beneficial ownership beyond their direct or indirect pecuniary interest.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 2,178,138 shares Apnimed common stock reported by Tao Capital Management
Percent of class 5.2% Portion of Apnimed common stock class held by Tao Capital Management
Tao Invest VI holding 891,813 shares Apnimed common stock held by Tao Invest VI LLC
Tao Invest VII holding 32,536 shares Apnimed common stock held by Tao Invest VII LLC
Tao Invest VIII holding 1,253,789 shares Apnimed common stock held by Tao Invest VIII LLC
Sole voting power 0 shares Shares over which Tao Capital Management has sole voting power
Shared voting power 2,178,138 shares Shares over which Tao Capital Management has shared voting power
beneficial ownership financial
"disclaim any beneficial ownership of such shares of Company common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power financial
"Shared Voting Power 2,178,138.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
dispositive power financial
"Shared Dispositive Power 2,178,138.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Schedule 13G regulatory
"form_type: "SCHEDULE 13G""
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
pecuniary interest financial
"except to the extent of their direct or indirect pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Apnimed (APMD) does Tao Capital Management report owning?

Tao Capital Management reports beneficial ownership of 5.2% of Apnimed’s common stock. This corresponds to 2,178,138 shares held through affiliated Tao Invest entities, with all voting and dispositive power reported as shared rather than sole.

How many Apnimed (APMD) shares does Tao Capital Management beneficially own?

Tao Capital Management reports beneficial ownership of 2,178,138 shares of Apnimed common stock. All of these shares are subject to shared voting and shared dispositive power through affiliated entities, rather than being controlled directly on a sole basis.

Which Tao Invest entities hold Apnimed (APMD) shares and in what amounts?

Apnimed shares are held by Tao Invest VI LLC with 891,813 shares, Tao Invest VII LLC with 32,536 shares, and Tao Invest VIII LLC with 1,253,789 shares. Together, these affiliated entities total 2,178,138 Apnimed common shares.

Does Tao Capital Management have sole voting power over its Apnimed (APMD) stake?

No. The filing reports 0 shares with sole voting power and 2,178,138 shares with shared voting power. Similarly, there is no sole dispositive power; all reported shares are subject to shared dispositive power among related entities.

How does Tao Capital Management describe its beneficial ownership of Apnimed (APMD)?

Tao Capital Management states that Tao Invest entities and related parties disclaim beneficial ownership of Apnimed shares except to the extent of their direct or indirect pecuniary interest. Voting and dispositive power is exercised through Tao Capital Management LP and Tao Capital Management Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





03770Y107

(CUSIP Number)
07/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Per the Apnimed, Inc. (Apnimed) prospectus shares of common stock issuable upon the deemed conversion of Apnimed redeemable convertible preferred stock and Convertible Notes are held by Tao Invest VI LLC (Tao VI), Tao Invest VII LLC (Tao VII) and Tao Invest VIII LLC (Tao VIII, together with Tao VI and Tao VII, Tao Invest). The managing member of Tao Invest is Tao Capital Management LP (Tao LP), whose general partner is Tao Capital Management Inc (Tao GP). Lori D. Mills and James Schwaba, as officers of Tao GP, have voting and dispositive power over the shares of Company common stock held by Tao Invest. Tao Invest, Tao LP and Tao GP, and the foregoing individuals disclaim any beneficial ownership of such shares of Company common stock except to the extent of their direct or indirect pecuniary interest therein.


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Tao Capital Management LP
Signature:/s/ James Schwaba
Name/Title:Managing Director
Date:08/06/2026
Tao Invest VI LLC
Signature:/s/ James Schwaba
Name/Title:Vice President
Date:08/06/2026
Tao Invest VII LLC
Signature:/s/ James Schwaba
Name/Title:Vice President
Date:08/06/2026
Tao Invest VIII LLC
Signature:/s/ James Schwaba
Name/Title:Vice President
Date:08/06/2026

Keep reading